Literature DB >> 20049507

Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales' disease by immunohistochemical analysis: a case report.

Aditya Verma1, Jyotirmay Biswas, Selvi Radhakrishnan, Angayarkanni Narayanasamy.   

Abstract

We report a immunohistochemical study of expression of VEGF and PEDF in Eales' disease. An enucleated eye from a patient with Eales' disease and an age and sex-matched donor eyeball were subjected to immunohistochemical and histopathological analysis to study the expression of VEGF and PEDF in the retinal region. Strong positive anti-VEGF immunostaining was found around the vessel walls in the retina in the eyeball from the Eales' disease patient compared with the donor control, from which it was almost absent. PEDF staining was detected in the normal donor eyeball retinal layers surrounding the blood vessels, and the photoreceptor and ganglion cell layer, whereas in the eyeball from Eales' disease patient PEDF staining was restricted to the surrounding blood vessels. The strong expression of VEGF in eyes with Eales' disease as opposed to weak expression of PEDF indicates the propensity of the disease to show neovascularization and recurrent hemorrhages.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049507     DOI: 10.1007/s10792-009-9338-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  27 in total

1.  Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle.

Authors:  T L Haas; M Milkiewicz; S J Davis; A L Zhou; S Egginton; M D Brown; J A Madri; O Hudlicka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology.

Authors:  N ASHTON
Journal:  Am J Ophthalmol       Date:  1957-10       Impact factor: 5.258

4.  Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.

Authors:  Ponnalagu Murugeswari; Dhananjay Shukla; Anand Rajendran; Ramasamy Kim; Perumalsamy Namperumalsamy; Veerappan Muthukkaruppan
Journal:  Retina       Date:  2008-06       Impact factor: 4.256

5.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

6.  Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage.

Authors:  V Bhooma; K N Sulochana; J Biswas; S Ramakrishnan
Journal:  Curr Eye Res       Date:  1997-02       Impact factor: 2.424

7.  Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.

Authors:  Antonella N Witmer; Harriet G Blaauwgeers; Herbert A Weich; Kari Alitalo; Gijs F J M Vrensen; Reinier O Schlingemann
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

8.  Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo.

Authors:  Hidenori Takahashi; Yasuhiro Tamaki; Nobuya Ishii; Nobuhiro Oikawa; Eisaku Mizuguchi; Jasmine H Francis; Yuji Inoue; Aya Iriyama; Ryo Obata; Yasuo Yanagi
Journal:  Curr Eye Res       Date:  2008-11       Impact factor: 2.424

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

Authors:  G Breier; U Albrecht; S Sterrer; W Risau
Journal:  Development       Date:  1992-02       Impact factor: 6.868

View more
  2 in total

1.  Intravitreal bevacizumab as an adjunct to vitrectomy in advanced Eales' disease.

Authors:  Meenakshi Thakar; Naina R Bamrolia; Usha Kaul Raina; Basudeb Ghosh
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-11-17

2.  Eales' disease: epidemiology, diagnostic and therapeutic concepts.

Authors:  Sergio Murillo López; Silvia Medina Medina; Fernando Murillo López
Journal:  Int J Retina Vitreous       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.